XML 49 R40.htm IDEA: XBRL DOCUMENT v3.23.3

Share-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

Equity awards compensation expense recorded in the consolidated statements of operations was as follows:

			Nine Months Ended
			2023						2022
			(in thousands)
Research and Development			(44,438)						(21,166)
Sales and Operations			(15,240)						(9,695)
General and Administrative			(16,675)						(11,733)
Total equity awards compensation expense			(76,353)						(42,594)
Tax benefit from equity awards compensation expense			6,084						4,409

The breakdown of the equity award compensation expense by instrument type was as follows:

			Nine Months Ended
			2023						2022
			(in thousands)
Share options			(80)						(47)
Lock-up shares			(28,326)						(7,088)
Restricted stock units / Performance stock units			(46,519)						(33,976)
Non-employee warrants			(1,428)						(1,483)
Total equity awards compensation expense			(76,353)						(42,594)
Tax benefit from equity awards compensation expense			6,084						4,409

A detailed description of each instrument type is provided below.

Schedule of Stock Options Roll Forward

			Options Outstanding
			Number of Shares Underlying Outstanding Options						Weighted-Average Exercise Price						Weighted-Average Remaining Contractual Term (Years)						Aggregate Intrinsic Value
						Outstanding as of December 31, 2022						372,329
Options granted			—
Options exercised			(41,417)
Options forfeited			(3,973)
Options canceled			—
Options expired			(1,861)
Outstanding as of September 30, 2023			325,078						€	20.88					4.37						€	11.46
Vested and exercisable as of September 30, 2023			301,611

Schedule of Nonvested Share Activity

			Shares						Weighted-Average Grant date Fair Value Per Share
						Outstanding as of December 31, 2022						2,960,243						—
						Granted						—						—
Vested			(1,006,482)						—
Forfeited			—						—
Outstanding as of September 30, 2023			1,953,761						€	23.94

Schedule of Nonvested Restricted Stock Units Activity

			Shares (RSU)						Weighted-Average Grant date Fair Value Per Share
						Outstanding as of December 31, 2022						5,349,955						—
						Granted						1,575,851						—
Vested			(1,116,711)						—
Forfeited			(340,383)						—
Outstanding as of September 30, 2023			5,468,712						€	26.2

Share-Based Payment Arrangement, Performance Shares, Activity

			Shares (PSU)						Weighted-Average Grant date Fair Value Per Share
						Outstanding as of December 31, 2022						522,467						—
						Granted						356,402						—
Vested			(173,092)						—
Forfeited			—						—
Outstanding as of September 30, 2023			705,777						€	27.94

Schedule of Stockholders' Equity Note, Warrants or Rights

			Shares						Weighted-Average Grant date Fair Value Per Share						Weighted-Average Remaining Contractual Term (Years)						Aggregate Intrinsic Value
						Outstanding as of December 31, 2022						302,775
						Granted						—
Exercised			(58,318)
Canceled			—
Expired			—
Outstanding as of September 30, 2023			244,457						€	17.65					4.73						€	12.98
Vested and exercisable - September 30, 2023			237,852

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the change in stock options.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-1

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Subparagraph (c)
-Paragraph 2
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration